olmesartan has been researched along with digitoxin in 1 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (digitoxin) | Trials (digitoxin) | Recent Studies (post-2010) (digitoxin) |
---|---|---|---|---|---|
841 | 185 | 554 | 5,259 | 90 | 219 |
Protein | Taxonomy | olmesartan (IC50) | digitoxin (IC50) |
---|---|---|---|
STAT3, partial | Homo sapiens (human) | 0.7 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
Sodium/potassium-transporting ATPase subunit alpha-1 | Homo sapiens (human) | 0.008 | |
Sodium/potassium-transporting ATPase subunit beta-1 | Homo sapiens (human) | 0.008 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.23 | |
Sodium/potassium-transporting ATPase subunit alpha-3 | Homo sapiens (human) | 0.008 | |
Sodium/potassium-transporting ATPase subunit beta-2 | Homo sapiens (human) | 0.008 | |
Sodium/potassium-transporting ATPase subunit alpha-2 | Homo sapiens (human) | 0.008 | |
Sodium/potassium-transporting ATPase subunit alpha-1 | Canis lupus familiaris (dog) | 0.008 | |
Sodium/potassium-transporting ATPase subunit beta-3 | Homo sapiens (human) | 0.008 | |
Sodium/potassium-transporting ATPase subunit gamma | Homo sapiens (human) | 0.008 | |
Sodium/potassium-transporting ATPase subunit alpha-4 | Homo sapiens (human) | 0.008 | |
Solute carrier organic anion transporter family member 4C1 | Homo sapiens (human) | 0.12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
1 other study(ies) available for olmesartan and digitoxin
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |